BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 21342274)

  • 21. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Mishra S; Tiwari V; Arora A; Gupta S; Anand N; Husain N
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2539-2547. PubMed ID: 32986350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma.
    Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD
    J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
    Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma.
    Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J
    J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of miRNA dynamics and cytokine profile in governing CD44v6/Nanog/PTEN axis in oral cancer: modulating the master regulators.
    Patel S; Rawal R
    Tumour Biol; 2016 Nov; 37(11):14565-14575. PubMed ID: 27612478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
    de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
    J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
    Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
    Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced chemosensitivity by targeting Nanog in head and neck squamous cell carcinomas.
    Huang CE; Yu CC; Hu FW; Chou MY; Tsai LL
    Int J Mol Sci; 2014 Aug; 15(9):14935-48. PubMed ID: 25158233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.
    Ghosh RD; Ghuwalewala S; Das P; Mandloi S; Alam SK; Chakraborty J; Sarkar S; Chakrabarti S; Panda CK; Roychoudhury S
    Sci Rep; 2016 Apr; 6():23932. PubMed ID: 27045798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC.
    Saha A; Roy S; Kar M; Roy S; Thakur S; Padhi S; Akhter Y; Banerjee B
    Stem Cell Rev Rep; 2018 Dec; 14(6):871-887. PubMed ID: 29872959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
    Moon Y; Kim D; Sohn H; Lim W
    Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.